233 related articles for article (PubMed ID: 18063506)
1. Suspected malignant hyperthermia during sevoflurane anesthesia.
Hsu SC; Huang WT; Yeh HM; Hsieh AY
J Chin Med Assoc; 2007 Nov; 70(11):507-10. PubMed ID: 18063506
[TBL] [Abstract][Full Text] [Related]
2. Anesthetic drugs and onset of malignant hyperthermia.
Visoiu M; Young MC; Wieland K; Brandom BW
Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
[TBL] [Abstract][Full Text] [Related]
3. Sudden death due to malignant hyperthermia with a mutation of RYR1: autopsy, morphology and genetic analysis.
Li W; Zhang L; Liang Y; Tong F; Zhou Y
Forensic Sci Med Pathol; 2017 Dec; 13(4):444-449. PubMed ID: 29101530
[TBL] [Abstract][Full Text] [Related]
4. Delayed onset of sevoflurane-induced juvenile malignant hyperthermia after second exposure.
Chen PL; Day YJ; Su BC; Lee PC; Chen CY
Acta Anaesthesiol Taiwan; 2007 Sep; 45(3):189-93. PubMed ID: 17972624
[TBL] [Abstract][Full Text] [Related]
5. Delayed onset of suspected malignant hyperthermia during sevoflurane anesthesia in an Afghan trauma patient: a case report.
Banek R; Weatherwax J; Spence D; Perry S; Muldoon S; Capacchione J
AANA J; 2013 Dec; 81(6):441-5. PubMed ID: 24597005
[TBL] [Abstract][Full Text] [Related]
6. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
Brandom BW; Muldoon SM
Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
[TBL] [Abstract][Full Text] [Related]
7. [Case of malignant hyperthermia in which treatment was carried out smoothly].
Morota T; Endo K; Furuta S; Obara S; Ohmuzo H; Kaneko T; Onuma T; Watanabe K
Masui; 2007 Jul; 56(7):826-30. PubMed ID: 17633846
[TBL] [Abstract][Full Text] [Related]
8. [Two pediatric cases of malignant hyperthermia caused by sevoflurane].
Kinouchi K; Okawa M; Fukumitsu K; Tachibana K; Kitamura S; Taniguchi A
Masui; 2001 Nov; 50(11):1232-5. PubMed ID: 11758332
[TBL] [Abstract][Full Text] [Related]
9. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Johannsen S; Klingler W; Schneiderbanger D; Heiderich S; Roewer N; Schuster F
Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
[TBL] [Abstract][Full Text] [Related]
10. [Anesthetic malignant hyperthermia and multiple organ dysfunction syndrome].
Brossier T; Gwinner N; Fontaine P; Girard C
Ann Fr Anesth Reanim; 2001 Aug; 20(7):647-50. PubMed ID: 11530754
[TBL] [Abstract][Full Text] [Related]
11. Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.
Swan H; Laitinen PJ; Toivonen L
Anesth Analg; 2004 Aug; 99(2):435-7, table of contents. PubMed ID: 15271719
[TBL] [Abstract][Full Text] [Related]
12. [A case of malignant hyperthermia arising five hours after the beginning of anaesthesia with sevoflurane and after five uneventful surgical procedures].
Barbier M; Lafaye AL; Guerin R; Viguier-Hourcastagnou L; Payen JF; Bazin JE
Ann Fr Anesth Reanim; 2009 Nov; 28(11):983-7. PubMed ID: 19910153
[TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia in the intensive care setting.
Schuster F; Moegele S; Johannsen S; Roewer N
Crit Care; 2014 Feb; 18(2):411. PubMed ID: 24602556
[No Abstract] [Full Text] [Related]
14. The severity of sevoflurane-induced malignant hyperthermia.
Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
[TBL] [Abstract][Full Text] [Related]
15. Repeat episodes of severe muscle rigidity in a child receiving sevoflurane.
Cohen IT; Kaplan R
Paediatr Anaesth; 2006 Oct; 16(10):1077-9. PubMed ID: 16972840
[TBL] [Abstract][Full Text] [Related]
16. [Case of fulminant-malignant hyperthermia occurring on sixth sevoflurane anesthesia].
Sugiyama K; Toya A; Shimomatsu K; Saitoh Y; Manabe Y; Kohjitani A
Masui; 2011 Jun; 60(6):703-5. PubMed ID: 21710767
[TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
[TBL] [Abstract][Full Text] [Related]
18. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.
Gonsalves SG; Dirksen RT; Sangkuhl K; Pulk R; Alvarellos M; Vo T; Hikino K; Roden D; Klein TE; Poler SM; Patel S; Caudle KE; Gordon R; Brandom B; Biesecker LG
Clin Pharmacol Ther; 2019 Jun; 105(6):1338-1344. PubMed ID: 30499100
[TBL] [Abstract][Full Text] [Related]
19. A rare case of malignant hyperthermia in the Indian subcontinent.
Gopalakrishnan CV; Suparna B; Arun V
Anaesthesia; 2010 Nov; 65(11):1141-2. PubMed ID: 20946392
[No Abstract] [Full Text] [Related]
20. MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT.
Almeida CG; Colleti Junior J
Rev Paul Pediatr; 2020; 38():e2018267. PubMed ID: 32074225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
